Herpes vaccines could mean billions of dollars of cost savings and prevent the loss of millions of quality of life years by reducing HSV-2 infections and HSV-2 driven HIV infections, according to a modelling study in 90 low and middle income countries
In your coverage, please use this URL to provide access to the freely available paper in PLOS Medicine: http://journals.plos.org/plosmedicine/article?id=10.1371/journal.pmed.1003938
Article Title: Estimated economic burden of genital herpes and HIV attributable to herpes simplex virus type 2 infections in 90 low- and middle-income countries: A modeling study
Author Countries: United States, Qatar
Funding: HHA acknowledges the joint support of Qatar University and Marubeni M-QJRC-2020-5. LJA acknowledges the support of NPRP grant number 9-040-3-008 from the Qatar National Research Fund (a member of Qatar Foundation). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
JOURNAL
PLoS Medicine
METHOD OF RESEARCH
Observational study
SUBJECT OF RESEARCH
People
No comments:
Post a Comment